Jagadish C. Sircar, VP of Drug Discovery at AVANIR PHARMACEUTICALS (AVN), sold 3,600 shares at $16.82 ($61K) on 2006-02-17, disclosed to the SEC on 2006-02-22.
Open-market sale of $61k AVN by VP of Drug Discovery. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.